ARCHIVES

GAO Recommends Tighter Policies on NIH Recusals.

This article is from The Cancer Letter archive.

Vol. 33 No. 25 | June 29, 2007

Download PDF Visit The Full Archive

Related Articles

In Brief: Million, Donaldson Head ASTRO; James Weese Moves To Presbyterian; Ginder Replaces Kennedy

November 9, 1990

Full Clearinghouse To Meet; Members Reveal Interests In Evaluations

October 28, 1977

Report Urges Changes To Cut Activation Times For NCI Phase III Trials.

April 9, 2010

FDA To Once Again Review ESA Label To Reflect Results Of Negative Studies.

December 7, 2007

Matrisian, Nelson, to lead review of NCI translational research programs.

September 23, 2005

Six-Year Follow Up Of Phase III Sprycel Trial Demonstrates 71 Percent Overall Survival

July 27, 2012